Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause

Por Portman, David J., Kaunitz, Andrew M., Kazempour, Kazem, Mekonnen, Hana, Bhaskar, Sailaja, Lippman, Joel
Publicado em 2014

The emerging role of obesity in short-acting hormonal contraceptive effectiveness

Por Edelman, Alison, Trussell, James, Aiken, Abigail R.A., Portman, David J., Chiodo, Joseph A., Garner, Elizabeth I. O.
Publicado no Contraception (2017)

Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial

Por Clayton, Anita H, Althof, Stanley E, Kingsberg, Sheryl, DeRogatis, Leonard R, Kroll, Robin, Goldstein, Irwin, Kaminetsky, Jed, Spana, Carl, Lucas, Johna, Jordan, Robert, Portman, David J
Publicado no Womens Health (Lond) (2016)

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

Por Archer, David F, Merkatz, Ruth B, Bahamondes, Luis, Westhoff, Carolyn L, Darney, Philip, Apter, Dan, Jensen, Jeffrey T, Brache, Vivian, Nelson, Anita L, Banks, Erika, Bártfai, György, Portman, David J, Plagianos, Marlena, Dart, Clint, Kumar, Narender, Creasy, George W, Sitruk-Ware, Regine, Blithe, Diana L
Publicado no Lancet Glob Health (2019)